Neurology

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

Neurology

Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J, Lubetzki C, Clanet M

An open label study of the effects of rituximab in neuromyelitis optica.

Neurology

Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C

The HLA locus and multiple sclerosis in Sicily.

Neurology

Brassat D, Salemi G, Barcellos LF, McNeill G, Proia P, Hauser SL, Oksenberg JR, Savettieri G

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.

Neurology

Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA, Glidden D, Weinstock-Guttman B, Reich D, Patterson N, Haines JL, Pericak-Vance M, DeLoa C, Oksenberg JR, Hauser SL

The shape of things to come.

Neurology

Hauser SL

Clinical characteristics of responders to interferon therapy for relapsing MS.

Neurology

Waubant E, Vukusic S, Gignoux L, Dubief FD, Achiti I, Blanc S, Renoux C, Confavreux C

IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.

Neurology

Waubant E, Goodkin D, Bostrom A, Bacchetti P, Hietpas J, Lindberg R, Leppert D

Pages